Derved forøges risikoen for alvorlig respiratorisk depression eller hæmatologiske anormaliteter eller andre alvorlige virkninger af disse midler.
Thereby, increasing the risk of serious respiratory depression or haematologic abnormalities, or other serious adverse effects from these agents.